Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Metcalf

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
The Journal of Clinical Investigation|September 9, 2025
A multiomics recovery factor predicts long COVID in the IMPACC studyGisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
Nature Microbiology|March 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19Abigail Glascock, Cole Maguire, Hoang Van Phan, et al.
JCI Insight|May 22, 2025
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19Anita E Qualls, Tasha Tsao, Irene Lui, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular SubtypingKexin Wang, Yutong Nie, Cole Maguire, et al.
Nature Communications|January 3, 2024
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC studyAl Ozonoff, Naresh Doni Jayavelu, Shanshan Liu, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
The Journal of Clinical Investigation|September 9, 2025
A multiomics recovery factor predicts long COVID in the IMPACC studyGisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
Nature Microbiology|March 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19Abigail Glascock, Cole Maguire, Hoang Van Phan, et al.
JCI Insight|May 22, 2025
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19Anita E Qualls, Tasha Tsao, Irene Lui, et al.
Biorxiv : the Preprint Server for Biology|December 9, 2024
Unraveling SARS-CoV-2 Host-Response Heterogeneity through Longitudinal Molecular SubtypingKexin Wang, Yutong Nie, Cole Maguire, et al.
Nature Communications|January 3, 2024
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC studyAl Ozonoff, Naresh Doni Jayavelu, Shanshan Liu, et al.
Pageof 18